Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 8;8(4):163-165.
doi: 10.1016/j.aace.2022.04.002. eCollection 2022 Jul-Aug.

Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin

Gina M Brock  1 , Sarah M Lane  2 , Theodore S Roosevelt  2
Affiliations
Case Reports

Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin

Gina M Brock et al. AACE Clin Case Rep. .

Abstract

Objective: Emphysematous cystitis (EC) is a rare urinary tract infection (UTI) typically associated with severe diabetes in older women. We present a unique case of this gas-forming infection in a man with type 2 diabetes mellitus (T2DM) treated with empagliflozin. To the best of our knowledge, this is the first case report of EC associated with the use of a sodium-glucose cotransporter 2 inhibitor (SGLT2i).

Case report: A 62-year-old man with T2DM treated with an SGLT2i developed EC. His moderately controlled T2DM was treated for over 20 years with metformin, saxagliptin/metformin, and pioglitazone to which empagliflozin was added due to his consistently elevated hemoglobin A1c level, slightly reduced estimated glomerular filtration rate, and proteinuria. Four months after initiation of the SGLT2i, he reported lower urinary tract symptoms and was found to have EC radiographically. His urine cultures were positive for Klebsiella pneumonia and was found to have asymptomatic urinary retention. He was treated conservatively, and his outcome was favorable.

Discussion: EC is commonly seen in patients with diabetes mellitus, and symptoms range from asymptomatic to severe sepsis. Most urine cultures grow Escherichia coli and K. pneumonia. The association of increased UTIs in susceptible patients with T2DM with the use of SGLT2i is yet to be determined. Most cases of EC are diagnosed radiographically and treated conservatively, although some cases require surgical intervention.

Conclusion: Initially, our patient was considered a good candidate for treatment with an SGLT2i. The subsequent development of EC precluded its further use. The role of SGLT2i in patients with T2DM susceptible to UTI is controversial.

Keywords: CT, computed tomography; EC, emphysematous cystitis; ER, extended-release; FG, Fournier gangrene; GU, genitourinary; HbA1c, hemoglobin A1c; LUT, lower urinary tract; PVR, postvoid residual; SGLT2 inhibitors; SGLT2i, sodium-glucose cotransporter 2 inhibitor; T2DM, type 2 diabetes mellitus; US, ultrasound; UTI, urinary tract infection; diabetes mellitus type 2; empagliflozin; emphysematous cystitis; urinary tract infection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Bladder ultrasound demonstrating echogenic gas in the bladder wall.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thomas A.A., Lane B.R., Thomas A.Z., Remer E.M., Campbell S.C., Shoskes D.A. Emphysematous cystitis: a review of 135 cases. BJU Int. 2007;100(1):17–20. - PubMed
    1. Amano M., Shimizu T. Emphysematous cystitis: a review of the literature. Intern Med. 2014;53(2):79–82. - PubMed
    1. Sharma J., Singhal J. A child with urosepsis and a bladder with a halo: answers. Pediatr Nephrol. 2020;35(1):75–76. - PubMed
    1. Yokoyama H. Incidence of severe urinary tract infections not increased by initiating sodium-glucose cotransporter 2 inhibitors. J Diabetes Investig. 2020;11(3):530–531. - PMC - PubMed
    1. Grayson D.E., Abbott R.M., Levy A.D., Sherman P.M. Emphysematous infections of the abdomen and pelvis: a pictorial review. Radiographics. 2002;22(3):543–561. - PubMed

Publication types